Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Carducci

Showing results (41-50 of 322) with videos related to

Pageof 33
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|September 16, 2011
Role of immunotherapy for renal cell cancer in 2011Saby George, Roberto Pili, Michael A Carducci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
The clinical application of targeting cancer through histone acetylation and hypomethylationJill Gilbert, Steve D Gore, James G Herman, et al.
Expert Opinion on Investigational Drugs|March 1, 2023
Role of bromodomain and extraterminal (BET) proteins in prostate cancerAdel Mandl, Mark C Markowski, Michael A Carducci, et al.
Trials|December 12, 2012
Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review studyNorma F Kanarek, Marty S Kanarek, Dare Olatoye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2013
Tales of how great drugs were brought down by a flawed rationale--letterMichel D Wissing, Michael A Carducci, Hans Gelderblom, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2007
Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugsHenk M W Verheul, David Z Qian, Michael A Carducci, et al.
The Journal of Supportive Oncology|May 22, 2012
What can I do? Recommendations for responding to issues identified by patient-reported outcomes assessments used in clinical practiceElizabeth F Hughes, Albert W Wu, Michael A Carducci, et al.
Hematology/Oncology Clinics of North America|November 6, 2013
Management of patients with biochemical recurrence after local therapy for prostate cancerChanning J Paller, Emmanuel S Antonarakis, Mario A Eisenberger, et al.
Clinical Advances in Hematology & Oncology : H&O|September 9, 2020
Problem Solving to Enhance Clinical Trial Participation Utilizing a Framework-Driven ApproachDina G Lansey, Taylor A Hefka, Michael A Carducci, et al.
Cancer|December 18, 2023
Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancerJohannes Thrul, Zofia Kozak, Michael A Carducci, et al.
Pageof 33

Showing results (41-50 of 322) with videos related to

Sort By:
Pageof 33
Journal of the National Comprehensive Cancer Network : JNCCN|September 16, 2011
Role of immunotherapy for renal cell cancer in 2011Saby George, Roberto Pili, Michael A Carducci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
The clinical application of targeting cancer through histone acetylation and hypomethylationJill Gilbert, Steve D Gore, James G Herman, et al.
Expert Opinion on Investigational Drugs|March 1, 2023
Role of bromodomain and extraterminal (BET) proteins in prostate cancerAdel Mandl, Mark C Markowski, Michael A Carducci, et al.
Trials|December 12, 2012
Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review studyNorma F Kanarek, Marty S Kanarek, Dare Olatoye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2013
Tales of how great drugs were brought down by a flawed rationale--letterMichel D Wissing, Michael A Carducci, Hans Gelderblom, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2007
Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugsHenk M W Verheul, David Z Qian, Michael A Carducci, et al.
The Journal of Supportive Oncology|May 22, 2012
What can I do? Recommendations for responding to issues identified by patient-reported outcomes assessments used in clinical practiceElizabeth F Hughes, Albert W Wu, Michael A Carducci, et al.
Hematology/Oncology Clinics of North America|November 6, 2013
Management of patients with biochemical recurrence after local therapy for prostate cancerChanning J Paller, Emmanuel S Antonarakis, Mario A Eisenberger, et al.
Clinical Advances in Hematology & Oncology : H&O|September 9, 2020
Problem Solving to Enhance Clinical Trial Participation Utilizing a Framework-Driven ApproachDina G Lansey, Taylor A Hefka, Michael A Carducci, et al.
Cancer|December 18, 2023
Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancerJohannes Thrul, Zofia Kozak, Michael A Carducci, et al.
Pageof 33